Combination epigenetic and immunotherapy overcomes resistance to monoclonal antibodies in hematologic malignancies: A new therapeutic approach.
Saved in:
| Title: | Combination epigenetic and immunotherapy overcomes resistance to monoclonal antibodies in hematologic malignancies: A new therapeutic approach. |
|---|---|
| Authors: | Epner EM; Sierra Epigenetics LLC, Granite Bay, CA. Electronic address: epner5@msn.com., Saroya BS; Department of Pathology, Windsor University, Cayon, St Kitts., Hasanali ZS; Department of Microbiology and Immunology, Pennsylvania State University College of Medicine and Penn State Hershey Cancer Institute, Hershey, PA., Loughran TP Jr; Department of Medicine/Hematology-Oncology, UVA Cancer Center, Charlottesville, VA. |
| Source: | Experimental hematology [Exp Hematol] 2016 Mar; Vol. 44 (3), pp. 157-60. Date of Electronic Publication: 2016 Jan 21. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Science Inc Country of Publication: Netherlands NLM ID: 0402313 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2399 (Electronic) Linking ISSN: 0301472X NLM ISO Abbreviation: Exp Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1873-2399 |
|---|---|
| DOI: | 10.1016/j.exphem.2015.12.011 |
